LUNGevity Foundation

I am proud to represent LUNGevity Foundation as an #advocate on the Cancer Grand Challenges Team CANCAN, working to solve the challenge of #cancer #cachexia. It's an amazing group of world experts, advocates and trainees, all dedicated to the mission. Pics from our recent retreat at CSHL. Eileen White Tobias Janowitz Marcus Goncalves Yvonne Diaz Ralph Stowe Amy Sutton Barry D. Stein

“I’ve always had running a marathon on my bucket list. Prior to my lung cancer, I had done a lot of 5k’s and some half marathons. I even ran a 5k just 10 days before I started coughing up blood. So when I saw that LUNGevity was going to be at the Paris Marathon and that I could sign up, I saw it as a beautiful opportunity to connect my love of running with lung cancer, two things that are really important to me,” says Katie. Learn more about Katie's story in our latest blog: https://brnw.ch/21wOQZN

Anyone with lungs can get lung cancer. This is Katie's story. We need your help to make lung cancer a national priority. Visit lungevity.org/lcam to get involved this Lung Cancer Awareness Month and beyond. You'll find activities you can do in your community to raise awareness. Thank you for helping us transform lung cancer. #AnyoneWithLungs #LCAM ALCSI?

I lost my Uncle Jerry to lung cancer 8 years ago. He was my role model -- a young, healthy, dad and an entrepreneur who never smoked a cigarette a day in his life. An important part of my personal life has been the fight against lung cancer. Under Jerry's leadership our family has helped raise millions of dollars for the LUNGevity Foundation on their fight to eradicate lung cancer. In a full-circle moment, my professional life intersects with that personal mission. Today we are launching our first Lung Cancer Screening CT course. Study after study after study have proved definitively, lung cancer screening saves lives. I'll repeat, lung cancer screening saves lives. And yet, adoption rates are abysmal around the world. These courses play an important role in educating radiologists and other physicians on how to do it. Fundamentals of Lung Cancer Screening Lung Cancer Screening CT Our sincerest gratitude to Ella A. Kazerooni from the University of Michigan for sharing her knowledge with the world. P.S. Studies are well documented by The Imaging Wire. P.P.S. Courses available here: https://lnkd.in/eZHwRgQY

LUNGevity is proud to announce the recipient of the 2024 Brown/LUNGevity Award to Understand Mechanisms of Resistance to Immunotherapy: Dr. Dwight O. (The Ohio State University) for his project Targeting Tumor-Associated Macrophages in Immunotherapy-Resistant NSCLC. Dr. Owen aims to tailor the body’s natural defense mechanisms to improve the effectiveness and duration of immunotherapy treatment. This research team aims to deepen our understanding of the role of tumor-associated macrophages (TAMs) – immune cells that are thought to promote tumor development and metastasis. The researchers will study hedgehog signaling, an important protein pathway that is likely to be involved in the crosstalk between TAMs, other parts of the immune system, and NSCLC cells. By disrupting hedgehog signaling in TAMs, Dr. Owen and his team aim to create an environment that is less favorable for cancer cell survival, allowing patients' immune systems to effectively combat the disease and overcome drug resistance to immunotherapy in NSCLC. “With the introduction of immune checkpoint inhibitors, the cancer community understood the power of removing obstacles for the patient’s natural immune system,” said Upal Basu Roy, PhD, MPH, executive director of LUNGevity Research. “However, acquired resistance is an issue in a major subset of patients. We are proud to partner with the Brown Family on this award to develop a novel opportunity to prolong the benefits of immunotherapy in NSCLC.” Learn more here: https://brnw.ch/21wONjh

Lung cancer is the leading cause of deaths so it must get the most federal funding for research, right? Wrong! Lung cancer receives only 6% of federal government dollars spent on cancer research. We need your help to raise awareness this November. Get active on social media and in your community to let everyone know #AnyoneWithLungs can get #lungcancer! Start here: lungevity.org/lcam

This year marks 20 years since researchers made a key discovery that changed the face of lung cancer research and treatment. By uncovering EGFR’s role in lung cancer, researchers developed a new class of drugs—targeted therapies—designed to target specific mutations in lung cancer cells, while leaving healthy cells unharmed. Watch Peters Solange Peters, MD, PhD, an internationally-acclaimed researcher and thoracic oncologist, share the story of EGFR’s role in lung cancer as she gave the keynote speech at the International Lung Cancer Survivorship Summit. https://lnkd.in/eP2E3hEP

Join LUNGevity’s Beth Dickson-Gavney and other experts for a CancerCare webinar to learn what’s new in non small cell lung cancer. Register now: https://lnkd.in/gD7Dj2pQ #lungcancer #lcsm

Biomarker testing has a vital role in the treatment of cancer. It ensures the right medicine reaches the right patient at the right time, embodying the hope of precision medicine.?? ? It's crucial for patients, caregivers and healthcare teams to prioritize biomarker testing at diagnosis.?? ? Amy C. Moore, PhD shares why she’s empowering patients to Talk, Test, Treat. Learn more about biomarker testing below: https://bit.ly/4hXXqXE ? #LungCancerAwarenessMonth #LCAM

How do we make sure clinical trial protocols align with the needs of lung cancer patients and their caregivers? Join Rising Tide Group and LUNGevity Foundation on November 20th for the second Facebook Live in a series of three, to explore how patients and researchers can work together to design clinical trial protocols that reduce the burden on patients and caregivers. The discussion will be moderated by Karolina Weryńska, PhD, Scientific Program Manager at Rising Tide Foundation for Clinical Cancer Research. She will be joined by guests, Janet Freeman-Daily, patient research advocate and co-founder of The ROS1ders, and Dr. D. Ross Camidge, Professor of Medicine-Medical Oncology at the University of Colorado. Tune in by visiting https://brnw.ch/21wODMO #LCAM #lungcancer #clinicaltrials #lungcancerresearch #cancerresearch #lcsm